The token is broken
Synchronizing patient journeys from registries and clinical trials to launch and beyond The...
Synchronizing patient journeys from registries and clinical trials to launch and beyond The...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Mental health treatment for women who are pregnant or lactating is crucial to ensure positive...
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
As therapies become increasingly complex and personalized, it is imperative that physicians...
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
As life settles into the new normal after the worst of the COVID-19 pandemic, it is clear that...
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
Ozempic and Semaglutide drive a 587% spike in GLP-1 prescriptions Prescriptions for GLP-1 receptor agonists, including Ozempic, Semaglutide, and Rybelsus, have surged over the last five years as their effectiveness in promoting weight loss gains atte...